Month-long postoperative radiotherapy and 5-FU improve survival in rectal cancer.
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy*; D015996:Survival Rate
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil